Sponsor Dossier
Merz
Sponsor Dossier for Merz. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: XEOMIN,
- Device (sponsor): Belotero Revive - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Radiesse Injectable Implant - Tissue reconstructive material, synthetic, fluid
- Device (sponsor): Belotero Balance Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Radiesse (+) Lidocaine - Dermal tissue reconstructive material, synthetic mineral, anaesthetic
- Device (sponsor): Belotero Lips Shape - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Soft Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Lips Contour - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Volume Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Intense Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Ultrasonic body-contouring system
- Device (sponsor): Transducer assembly, ultrasound, therapeutic, hyperthermia, extracorporeal
About
Merz is an Australian Private Company with ABN 62151073559, registered in NSW and currently active. The company operates under the trading name Merz Aesthetics.
Portfolio
Merz has 1 brand on the ARTG, of which 1 is indexable and 1 carries a Product Information document. 1 brand is PBS-listed, 1 has a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include XEOMIN,.
Therapeutic focus
— Neurology: 1 brand
PBS footprint
1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 1 brand with a PBAC outcome on record. The latest AusPAR is 2015-09-17, across 1 brand with an AusPAR on record.